Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
Top Cited Papers
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 8 (1) , 57-64
- https://doi.org/10.1016/j.coph.2007.12.002
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− MiceNeuron, 2004
- Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease MiceJournal of Neuroscience, 2003
- Deacetylase Activity Is Required for cAMP Activation of a Subset of CREB Target GenesJournal of Biological Chemistry, 2003
- A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4Proceedings of the National Academy of Sciences, 2003
- Mechanisms, challenges and opportunities in strokeNature Reviews Neuroscience, 2003
- Transcriptional abnormalities in Huntington diseaseTrends in Genetics, 2003
- Ischemic Insults Derepress the Gene Silencer REST in Neurons Destined to DieJournal of Neuroscience, 2003
- Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseaseProceedings of the National Academy of Sciences, 2003
- Molecular Genetics of Human CognitionMolecular Interventions, 2002
- Neurological disease: listening to gene silencers.2001